Cetagliptin/Metformin

盛格列汀/二甲双胍

Report date: 2024/12/06 11:13:14

Base Information

Drug NameCetagliptin/Metformin
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Sentagliptin PhosphateMetformin Hydrochloride
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCgenetech(Suzhou China) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCgenetech(Suzhou China) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A